<DOC>
	<DOC>NCT01189812</DOC>
	<brief_summary>The investigators hypothesize that patients receiving citalopram in combination with lithium will have a greater reduction in depressive symptoms than patients receiving citalopram in combination with placebo.</brief_summary>
	<brief_title>Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1875 years of age Meets criteria for Major Depressive Disorder, Dysthymia, Depression Not Otherwise Specified or Borderline Personality Disorder Ability to speak, read and understand the English Language and provide written informed consent Current, unstable and significant medical condition or illness History of Thyroid disorder, seizure disorder, tumors or other CNS condition that predisposes the patient to risk of seizure Pregnant or lactating females Abnormal clinical laboratory test results Intolerance or hypersensitivity to SSRIs or lithium History or current diagnosis of bipolar mood disorder, psychosis, schizophrenia or dementia Certain mediations my not be used prior or during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>hopelessness</keyword>
	<keyword>alone</keyword>
	<keyword>sad</keyword>
	<keyword>troubled</keyword>
	<keyword>depression</keyword>
</DOC>